9885.HK
111 Inc. is a healthcare company

Pharmaceutical e-commerce platform YSB Inc. (9885.HK) announced on Thursday that it expects to record a net profit of 70 million yuan ($9.75 million) or more for the six months through June, more than triple the 21.8 million yuan it reported a year earlier.

The company credited the surge to steady revenue growth, strong demand for its high-margin self-branded products, and enhanced digital capabilities that improved the efficiency of its platform and direct-sales operations.

YSB‘s stock opened higher on Friday but later turn lower, closing at HK$10.02 by the midday break, down 2.34%. The stock is up 67.9% this year.

By Lee Shih Ta

To subscribe to Bamboo Works weekly free newsletter, click here

Recent Articles

Video podcast: Cango to build on bitcoin mining foundation with HPC pivot

Cango details the strategic pivot to transform from a pure-play crypto miner into an integrated energy and high-performance computing (HPC) platform. The multi-phase strategy leverages Cango's existing energy and computing infrastructure as a foundation to build a more diverse business model with revenues from mining, AI client services, and energy trading.